Boddu Ravindra, Yang Chaozhe, O'Connor Amber K, Hendrickson Robert Curtis, Boone Braden, Cui Xiangqin, Garcia-Gonzalez Miguel, Igarashi Peter, Onuchic Luiz F, Germino Gregory G, Guay-Woodford Lisa M
Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
J Mol Med (Berl). 2014 Oct;92(10):1045-56. doi: 10.1007/s00109-014-1185-7. Epub 2014 Jul 3.
Autosomal recessive polycystic kidney disease (ARPKD) results from mutations in the human PKHD1 gene. Both this gene, and its mouse ortholog, Pkhd1, are primarily expressed in renal and biliary ductal structures. The mouse protein product, fibrocystin/polyductin complex (FPC), is a 445-kDa protein encoded by a 67-exon transcript that spans >500 kb of genomic DNA. In the current study, we observed multiple alternatively spliced Pkhd1 transcripts that varied in size and exon composition in embryonic mouse kidney, liver, and placenta samples, as well as among adult mouse pancreas, brain, heart, lung, testes, liver, and kidney. Using reverse transcription PCR and RNASeq, we identified 22 novel Pkhd1 kidney transcripts with unique exon junctions. Various mechanisms of alternative splicing were observed, including exon skipping, use of alternate acceptor/donor splice sites, and inclusion of novel exons. Bioinformatic analyses identified, and exon-trapping minigene experiments validated, consensus binding sites for serine/arginine-rich proteins that modulate alternative splicing. Using site-directed mutagenesis, we examined the functional importance of selected splice enhancers. In addition, we demonstrated that many of the novel transcripts were polysome bound, thus likely translated. Finally, we determined that the human PKHD1 R760H missense variant alters a splice enhancer motif that disrupts exon splicing in vitro and is predicted to truncate the protein. Taken together, these data provide evidence of the complex transcriptional regulation of Pkhd1/PKHD1 and identified motifs that regulate its splicing. Our studies indicate that Pkhd1/PKHD1 transcription is modulated, in part by intragenic factors, suggesting that aberrant PKHD1 splicing represents an unappreciated pathogenic mechanism in ARPKD. Key messages: Multiple mRNA transcripts are generated for Pkhd1 in renal tissues Pkhd1 transcription is modulated by standard splice elements and effectors Mutations in splice motifs may alter splicing to generate nonfunctional peptides.
常染色体隐性多囊肾病(ARPKD)是由人类PKHD1基因突变引起的。该基因及其小鼠同源基因Pkhd1主要在肾和胆管结构中表达。小鼠蛋白产物纤维囊肿蛋白/多囊蛋白复合物(FPC)是一种由67个外显子转录本编码的445 kDa蛋白,该转录本跨越>500 kb的基因组DNA。在本研究中,我们在胚胎小鼠肾脏、肝脏和胎盘样本以及成年小鼠胰腺、大脑、心脏、肺、睾丸、肝脏和肾脏中观察到多个大小和外显子组成不同的可变剪接Pkhd1转录本。使用逆转录PCR和RNA测序,我们鉴定了22个具有独特外显子连接的新型Pkhd1肾脏转录本。观察到多种可变剪接机制,包括外显子跳跃、使用替代的受体/供体剪接位点以及包含新的外显子。生物信息学分析鉴定并通过外显子捕获微型基因实验验证了调节可变剪接的富含丝氨酸/精氨酸蛋白的共有结合位点。使用定点诱变,我们研究了选定剪接增强子的功能重要性。此外,我们证明许多新型转录本与多核糖体结合,因此可能被翻译。最后,我们确定人类PKHD1 R760H错义变体改变了一个剪接增强子基序,该基序在体外破坏外显子剪接,并预计会截断蛋白质。综上所述,这些数据提供了Pkhd1/PKHD1复杂转录调控的证据,并鉴定了调节其剪接的基序。我们的研究表明,Pkhd1/PKHD1转录部分受基因内因子调节,这表明异常的PKHD1剪接代表了ARPKD中一种未被认识的致病机制。关键信息:肾组织中产生多种Pkhd1 mRNA转录本;Pkhd1转录受标准剪接元件和效应器调节;剪接基序中的突变可能改变剪接以产生无功能的肽。